©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: Drug Enforcement Administration
DEA Judge Hits Pause on Cannabis Rescheduling
WASHINGTON – Cannabis rescheduling is up in the air again after the administrative law judge assigned to hear arguments for and against the proposal...
Americans for Safe Access Calls for Compassionate Leadership Amid DEA Hearing Delay
WASHINGTON — In light of the Drug
Enforcement Administration’s (DEA) announcement to schedule a hearing
on the rescheduling of cannabis, Americans for Safe Access (ASA)
emphasizes the urgent...
Cannabis Stocks Tumble on News of DEA’s Rescheduling Shakeup
NEW YORK – Shares of publicly traded cannabis companies felt investors’ dissatisfaction following the Drug Enforcement Administration’s (DEA) announcement it will hold a public...
IRS Reaffirms Marijuana’s Status Under Federal Tax Law
WASHINGTON – The Internal Revenue Service (IRS) has reiterated marijuana remains classified as a Schedule I controlled substance, and businesses involved in manufacturing, distribution,...
KCSA Urges DOJ to Reschedule Cannabis
NEW YORK -- KCSA Strategic Communications, a leading integrated communications firm, has formally expressed its support for the rescheduling of cannabis under the Controlled Substances...
United for Decrim Launches Digital Public Comment Tool
WASHINGTON – United for Marijuana Decriminalization (UMD), a coalition of prominent drug and marijuana policy reform organizations, has launched a digital public comment tool...
DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Not Classified as Controlled Substance
MIAMI -- MIRA Pharmaceuticals Inc., a pre-clinical-stage pharmaceutical company focused on the treatment of neurologic and neuropsychiatric disorders, announced that MIRA-55, has been determined by...
It’s Official: DOJ Proposes Rescheduling Cannabis
WASHINGTON – It’s official: On Thursday, the Department of Justice (DOJ) proposed moving cannabis from Schedule I to Schedule III under the Controlled Substances...
Congressional Report Confirms Changing Marijuana to a Schedule III Drug Would Maintain Federal Criminalization
WASHINGTON – A new report from the Congressional Research Service (CRS) confirms that marijuana would remain criminalized under federal law if moved to Schedule...
Why Cannabis Research and Outcomes Matter
There is so much potential in cannabis. It can help to alleviate chronic pain caused by a number of health conditions. It can reduce...